Open AccessOptimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial
Author(s) -
Ben Gombe,
Claire Streatfield,
Lorna Leal,
Solomon Opio,
Sarah Joseph,
Jonathan Weber,
Jonathan Hare,
Pontiano Kaleebu,
Jennifer Serwanga
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0275927
Subject(s) - vaccination , hiv vaccine , placebo , medicine , context (archaeology) , vaccine trial , immunology , clinical trial , virology , antibody titer , titer , dna vaccination , antibody , vaccine efficacy , clinical endpoint , biology , alternative medicine , immunization , pathology , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom